Overview of Frontline2

The understanding of best practice for preventing and treating thrombosis in cancer patients has evolved since the first Frontline survey in 2001, but contemporary evidence suggests that variations in practice still persist.[1],[2]

Frontline2 is a cancer associated thrombosis (CAT) survey of oncologists, haematologists, surgeons, thrombosis specialists, members of the palliative care team and specialist nurses to identify the factors and evidence that now inform the decisions made by those responsible for treating CAT. This will provide an opportunity to describe the evolution of clinical understanding in this area since 2001, and the rationale behind variations in care, nationally and internationally, in 2016.

Key survey objectives will be the assessment of:

  • The awareness of current guidelines for the management of CAT
  • The use of anticoagulants for the acute management of CAT
    • Patient types and characteristics
    • Preferred treatment agents
    • Duration of therapy
  • The use of and extended treatment duration (greater than 6 months) for prevention of subsequent CAT
    • Patient types and characteristics
    • Preferred treatment agents
  • The use of thromboprophylaxis in patients receiving active chemotherapy

[1] Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8(4):381-8. To view the full Frontline1 paper click here [2] Amin A, Stemkowski S, Lin J, Yang G. Appropriate thromboprophylaxis in hospitalized cancer patients. Clin Adv Hematol Oncol. 2008;6(12):910-20.

As a thank you we have prepared some free educational materials that we hope will be of use to you; you can find these in the ‘Free Educational Materials’ section after completing the survey.